miR‐486‐5p, miR‐98‐5p, miR‐25‐3p, miR‐20b‐5p, and miR‐16‐5p, which were all highly differentially expressed in PCD patients, were found to target both the CDR2L and RPS6 genes using the DIANA‐TarBase database of experimentally supported miRNA–gene interactions. The gene discussed is CDR2L; the disease is paraneoplastic neurologic syndrome.